HopeStage
Back to all studies
UnknownNCT05945342

Development and Application of Comprehensive Intervention Techniques for Adolescent Depression

Medication studyAges 12–18China
The study in practice

Understand this study

Who could participate?

Listed age limits: 12 years to 18 years.

Listed locations
HangzhouSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 31, 2023
Recruitment status
Unknown
Enrollment listed in the registry
100
Sponsor
First Affiliated Hospital of Zhejiang University
Sponsor type
University
Study type
Drug
Intervention type
Drug, Other
Locations
China
Age range
From 12 Years to 18 Years
Official registry ID
NCT05945342
Official title
Show the full official title

Research and Application of Key Technologies for Early Identification, Risk Warning and Comprehensive Intervention of Adolescent Depression

Recruitment & locations

Status unknown

Hangzhou

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is First Affiliated Hospital of Zhejiang University, a university.

Does this study involve medication?

Yes. The study involves medication, including Escitalopram and Escitalopram combined with sham rTMS.

Who can participate?

Listed age limits: 12 years to 18 years.

Want to explore more studies?

Explore studies